Tenax Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TENX Nasdaq 2830 www.tenaxthera.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tenax Therapeutics, Inc.

Tenax Therapeutics (TENX) Stock Fair Value Falls After Cautious Analyst Calls On LEVEL Data - Oct 24th, 2026 7:16 pm
Tenax (TENX) Found a 26.3-Meter Benefit in a Prespecified Subgroup After LEVEL Missed Its Primary Endpoint. Is Another Phase 3 Trial Viable? - Sep 4th, 2026 4:26 pm
Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - Sep 1st, 2026 5:00 am
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls - Aug 31st, 2026 7:45 am
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 - Aug 29th, 2026 6:21 am
Tenax Therapeutics’ stock crashes on Phase III trial failure - Aug 11th, 2026 5:15 am
Tenax LEVEL Trial Misses Primary Goal, but Subgroup Data Bolsters Levosimendan Case - Aug 11th, 2026 12:01 am
Tenax Therapeutics Phase 3 LEVEL Trial Misses Primary Endpoint for TNX-103 - Aug 10th, 2026 9:03 am
Why Did TENX Stock Crash 89% Today? - Aug 10th, 2026 8:23 am
Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout - Aug 10th, 2026 6:25 am
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Jul 31st, 2026 5:00 am
Wall Street Analysts Predict a 121.36% Upside in Tenax Therapeutics (TENX): Here's What You Should Know - Jul 21st, 2026 7:55 am
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jul 2nd, 2026 2:05 pm
Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026 - Jul 2nd, 2026 5:00 am
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - May 12th, 2026 5:00 am
Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer - May 4th, 2026 5:00 am
Companies Like Tenax Therapeutics (NASDAQ:TENX) Are In A Position To Invest In Growth - Apr 22nd, 2026 7:20 am